Long COVID in patients infected before COVID vaccines became available: Carfì et al, "Persistent Symptoms in Patients After Acute COVID-19", JAMA (July 2000), https://t.co/nBvP25pG7p 20/34
Persistent Symptoms in Patients After Acute COVID-19.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jul 2020 – Nov 2025Where it's discussed
-
News444 articles
-
X / Twitter362 posts
-
Facebook36 posts
-
Blogs34 articles
-
Reddit10 posts
-
YouTube5 videos
-
Bluesky1 posts
AI synopsis
What people are saying
This collection of discussions demonstrates a broad consensus on the reality of long COVID, as evidenced by references to early studies from 2020 showing widespread symptoms like fatigue and dyspnea even before vaccines existed. The tone varies from scientific citations, such as Carfi et al.'s research, to personal anecdotes, highlighting the significance and personal impact of persistent symptoms, which collectively substantiate the high agreement, interest, engagement, and potential influence of this issue.
Most discussions strongly support and acknowledge the findings of the publication, emphasizing that persistent symptoms post-COVID are well-documented and real.
Posts display high interest by referencing various studies, sharing personal experiences, and emphasizing long-term effects, indicating active engagement with the subject.
Many discussions involve detailed data analysis, citations of authoritative sources, and debates over the significance of long COVID, showing deep engagement.
The attention drawn to persistent symptoms and long COVID suggests these discussions could influence public health policies and awareness, reflecting a high impact.
Abstract in brief
- The study focuses on Italian patients who experienced COVID-19 symptoms that continued for about 60 days after their initial illness.
- It highlights the issue of "long COVID," where symptoms persist long after the patient has been discharged from the hospital.
- The case series aims to understand the duration and nature of these ongoing symptoms to better inform post-COVID care.]
Top posts
Most liked on X and BlueskyBy July 2020 persistent symptoms (Carfi et al.) and sequelae such as cardiac complications even in mild/asymptomatic patients (Puntmann et al.) after Covid were being reported in major medical journal, like JAMA https://t.co/RA22Pxu1gB https://t.co/WnH1RQh6gr
・mRNAワクチンの臨床試験 https://t.co/IYOklKwRau ・mRNAワクチンの副反応 https://t.co/fl3C7wIfH7 ・COVID-19患者の、退院後60日の再入院率と死亡率 https://t.co/BoweYq85Rz ・COVID-19と季節性インフルエンザの比較 https://t.co/fiLGWpPPky ・COVID-19患者の後遺症調査 https://t.co/37dEmeaX9o
#COVID19 akut hastalığı atlattıktan sonra, bir süre daha devam eden semptomlar: yorgunluk, nefes darlığı, eklem ve göğüs ağrısı, öksürük, tat ve koku alamama, sjögren sendromu, baş ağrısı, boğaz ağrısı.. https://t.co/B7OKdZHSr2
• اضطراب في التركيز • صداع • تسارع دقات القلب • فقدان حاسة الشم و الذوق • الاكتئاب و القلق • الدوار • الحمى [المرجع بتصرف: Carfi A, et al. Persistent symptoms in patients after acute COVID-19. JAMA. 2020; doi:10.1001/jama.2020.12603. Teneforde MW, et al. ]
#COVID19: ACTUALIZACIÓN | PREGUNTAS Y RESPUESTAS | VACUNA #PFIZER, REINFECCIONES, INMUNIDAD, SECUELAS HOY • 20:00 hrs • #YouTube https://t.co/PrtGvbypAs Realizamos una actualización de #COVID19 con fundamento científico y memes de #BobEsponja acerca de esta enfermedad. https://t.co/ZxnSwLv9D5
All mentions
COVID-19 Update: Vaccine, Re-infections, and Food Safety Insights
Today, we provide a concise update addressing frequently asked questions about COVID-19. This video emphasizes the impact of the pandemic on food safety practices, highlighting the importance of hygiene in food handling…
Long COVID Symptoms and Complications Post-Infection
COVID-19 can be asymptomatic or mild for most, but long-term complications like heart failure, organ damage, and neurological issues can occur. Post-COVID effects may significantly impact quality of life and require…
Understanding Post-COVID Symptoms: Insights and Findings
Thank you to everyone who joined our livestream discussing COVID-19. We will return on September 19, 2020. This session features a specialist discussing persistent symptoms in recovered patients. It's crucial to…
Understanding Long COVID Symptoms and Post-Recovery Risks
This video discusses COVID-19 symptoms, including fever, headache, anosmia, skin rashes, cough, and breathing difficulties. It emphasizes the importance of understanding long-term symptoms and post-recovery…
Understanding Long COVID: Symptoms and Recovery Insights
It's one thing to get COVID but another to not get better. Long COVID is affecting many individuals, revealing persistent symptoms even after the acute phase. This video discusses emerging research, the impact of…
新型コロナの慢性症状 伊143症例の検討 初発から平均60.3日の評価 症状完全消失は12.6%のみ。32%は1か2、55%は3以上の症状。QOL悪化は44.1% 疲労、呼吸困難、関節痛、胸痛を報告した人の割合が高い‥等々 https://t.co/lm0szwjfLf
新型コロナの慢性症状 伊143症例の検討 初発から平均60.3日の評価 症状完全消失は12.6%のみ。32%は1か2、55%は3以上の症状。QOL悪化は44.1% 疲労、呼吸困難、関節痛、胸痛を報告した人の割合が高い‥等々 https://t.co/lm0szwjfLf
RT @wolfeagle1989: Long COVID in patients infected before COVID vaccines became available: Carfì et al, "Persistent Symptoms in Patients Af…
RT @wolfeagle1989: Long COVID in patients infected before COVID vaccines became available: Carfì et al, "Persistent Symptoms in Patients Af…
RT @wolfeagle1989: Long COVID in patients infected before COVID vaccines became available: Carfì et al, "Persistent Symptoms in Patients Af…
RT @wolfeagle1989: Long COVID in patients infected before COVID vaccines became available: Carfì et al, "Persistent Symptoms in Patients Af…
RT @wolfeagle1989: Long COVID in patients infected before COVID vaccines became available: Carfì et al, "Persistent Symptoms in Patients Af…
RT @wolfeagle1989: Long COVID in patients infected before COVID vaccines became available: Carfì et al, "Persistent Symptoms in Patients Af…
RT @wolfeagle1989: Long COVID in patients infected before COVID vaccines became available: Carfì et al, "Persistent Symptoms in Patients Af…
RT @wolfeagle1989: Long COVID in patients infected before COVID vaccines became available: Carfì et al, "Persistent Symptoms in Patients Af…
RT @wolfeagle1989: Long COVID in patients infected before COVID vaccines became available: Carfì et al, "Persistent Symptoms in Patients Af…
RT @wolfeagle1989: Long COVID in patients infected before COVID vaccines became available: Carfì et al, "Persistent Symptoms in Patients Af…
RT @wolfeagle1989: Long COVID in patients infected before COVID vaccines became available: Carfì et al, "Persistent Symptoms in Patients Af…
RT @wolfeagle1989: Long COVID in patients infected before COVID vaccines became available: Carfì et al, "Persistent Symptoms in Patients Af…
RT @wolfeagle1989: Long COVID in patients infected before COVID vaccines became available: Carfì et al, "Persistent Symptoms in Patients Af…
RT @wolfeagle1989: Long COVID in patients infected before COVID vaccines became available: Carfì et al, "Persistent Symptoms in Patients Af…
RT @wolfeagle1989: Long COVID in patients infected before COVID vaccines became available: Carfì et al, "Persistent Symptoms in Patients Af…
RT @wolfeagle1989: Long COVID in patients infected before COVID vaccines became available: Carfì et al, "Persistent Symptoms in Patients Af…
Long COVID in patients infected before COVID vaccines became available: Carfì et al, "Persistent Symptoms in Patients After Acute COVID-19", JAMA (July 2000), https://t.co/nBvP25pG7p 20/34
RT @sug100foroba: 新型コロナの慢性症状 伊143症例の検討 初発から平均60.3日の評価 症状完全消失は12.6%のみ。32%は1か2、55%は3以上の症状。QOL悪化は44.1% 疲労、呼吸困難、関節痛、胸痛を報告した人の割合が高い‥等々 https…
新型コロナの慢性症状 伊143症例の検討 初発から平均60.3日の評価 症状完全消失は12.6%のみ。32%は1か2、55%は3以上の症状。QOL悪化は44.1% 疲労、呼吸困難、関節痛、胸痛を報告した人の割合が高い‥等々 https://t.co/lm0szwjfLf
RT @sug100foroba: 新型コロナの慢性症状 伊143症例の検討 初発から平均60.3日の評価 症状完全消失は12.6%のみ。32%は1か2、55%は3以上の症状。QOL悪化は44.1% 疲労、呼吸困難、関節痛、胸痛を報告した人の割合が高い‥等々 https…
新型コロナの慢性症状 伊143症例の検討 初発から平均60.3日の評価 症状完全消失は12.6%のみ。32%は1か2、55%は3以上の症状。QOL悪化は44.1% 疲労、呼吸困難、関節痛、胸痛を報告した人の割合が高い‥等々 https://t.co/lm0szwjfLf
@BBarucker @wodarg @elisaperego78 https://t.co/yMRf7Sb4mb https://t.co/f1fbW1PIHV
新型コロナの慢性症状 伊143症例の検討 初発から平均60.3日の評価 症状完全消失は12.6%のみ。32%は1か2、55%は3以上の症状。QOL悪化は44.1% 疲労、呼吸困難、関節痛、胸痛を報告した人の割合が高い‥等々 https://t.co/lm0szwjfLf
@KrotenKoker010 Omdat je blijkbaar het IQ van een uitgedroogde tomaat hebt… ga ik je helpen. Het is wetenschappelijke literatuur, dus ik snap dat wellicht ver boven je pet gaat: https://t.co/uDZqfrqpEE https://t.co/ugbFA0CtXz https://t.co/WLdfimsrWF https://t.co/rra2nvsEk5 Enz enz enz
@MonikaGruber24 Oder, #PreVac Fakten, der Knoblauch für Schwurbis: https://t.co/LpTaTGQv8F
@SalvMattera @Mangan150 @Ayjchan Here’s one of those studies discussing Long COVID early on. It was *published* in July 2020. https://t.co/nBvP25pG7p
Long COVID in the unvaccinated: Long COVID happened before vaccines were available https://t.co/GSKAv8SWDZ (infected January 2020), https://t.co/SwfVYnednZ (published July 2020) 18/33
@kowalski49870 @globalhlthtwit “Long vaccination” happens, but Long COVID happened before vaccines were available https://t.co/GSKAv8SWDZ (infected January 2020), https://t.co/SwfVYnednZ (published July 2020) 1/5
I also accept the existence of Long COVID without vaccination (Gottlieb et al https://t.co/eke05YYmaV; Carfì et al https://t.co/SwfVYnednZ; Del Rio et al https://t.co/sIW46qS4Ev; New report of Long COVID from COVID symptoms starting January 23, 2020: https://t.co/GSKAv8SWDZ). 2/5
RT @wolfeagle1989: @rlawless187 @SocraticaKim @ryan_zickgraf Personally, around April or May 2020 I reasoned from post-polio syndrome and s…
RT @wolfeagle1989: @rlawless187 @SocraticaKim @ryan_zickgraf Personally, around April or May 2020 I reasoned from post-polio syndrome and s…
RT @wolfeagle1989: @rlawless187 @SocraticaKim @ryan_zickgraf Personally, around April or May 2020 I reasoned from post-polio syndrome and s…
@rlawless187 @SocraticaKim @ryan_zickgraf Personally, around April or May 2020 I reasoned from post-polio syndrome and shingles (essentially a delayed long chickenpox) that a post-acute COVID syndrome was a risk. And then in July or August 2020 I came across some published evidence: Carfì et al https://t.co/SwfVYnednZ.
RT @elisaperego78: e.g. https://t.co/xOMomsFxZ4
RT @elisaperego78: e.g. https://t.co/xOMomsFxZ4
e.g. https://t.co/xOMomsFxZ4
@Michael94617501 @elisaperego78 Carfì et al https://t.co/nBvP25pG7p also published on COVID survivors experiencing Long COVID as early as July 2020. Again, this was well before COVID vaccinations became available.
@FMr9io1HYJ8dlwJ 勿論読んでますよ。 山ほどあるけど? 貴方はどうせ読まないだろうけど、ひとつ貼り付けとくよ 足りなければいくらでも言ってね
@STTDB1984 @Solahmi_ @dr_andrealove Go into the comments of any large enough tweet about covid and you'll find people saying yeah I think the vax is bad but me or someone I know got long covid before the vax was even out, it's very real. Note the dates on these https://t.co/EF3h97rM30 https://t.co/rBqXxjw0ch
@tlar @termined_d @MelpomeneMel @TRyanGregory Articles began showing up as early as March and April: https://t.co/gBRXpfFGdf These articles are all from the summer of 2020: https://t.co/x31w6fzfPw https://t.co/IMTG5uBYr4 https://t.co/iPNuEZyLi1 https://t.co/hVzzeiax8F
@JoniHaimakka @anssi_ope @Aki_Nummelin Kuinka tuo on mahdollista kun tutkimuksia Long Covidista löytyy puoli vuotta ennen ensimmäisenkään rokotteen kehittämistä??? https://t.co/MZBFU5vZ2b
@glizzard115 @abcnews No vaxes in 2020, but plenty of long covid: https://t.co/GDqhZQTWY4
RT @elisaperego78: Study with limitations, including the short time period of examination. But confirms a rich body of literature since the…
RT @elisaperego78: Study with limitations, including the short time period of examination. But confirms a rich body of literature since the…
RT @elisaperego78: Study with limitations, including the short time period of examination. But confirms a rich body of literature since the…
RT @elisaperego78: Study with limitations, including the short time period of examination. But confirms a rich body of literature since the…
RT @elisaperego78: Study with limitations, including the short time period of examination. But confirms a rich body of literature since the…
RT @elisaperego78: Study with limitations, including the short time period of examination. But confirms a rich body of literature since the…
Study with limitations, including the short time period of examination. But confirms a rich body of literature since the early pandemic showing a very high percentage of hospitalized Covid survivors present prolonged pathology, symptoms post discharge https://t.co/WnH1RQhE5Z
RT @elisaperego78: @WHO @Nature Sequelae in organs such as the heart and the existence of persistent symptoms post infection were reported…
@WHO @Nature Sequelae in organs such as the heart and the existence of persistent symptoms post infection were reported in prominent medical journals like @JAMANetwork already in summer 2020 (e.g. Puntmann et al. 2020; Carfi et al. 2020) https://t.co/WnH1RQh6gr https://t.co/RA22Pxu1gB
@Krag474 @theheraldsun July 2020 https://t.co/UGmhtTo59w
@Krag474 @theheraldsun Here you go love https://t.co/UGmhtTo59w
@Krag474 @theheraldsun July 19, 2020 (waaay before the vaccines): “This study found that in patients who had recovered from COVID-19, 87.4% reported persistence of at least 1 symptom, particularly fatigue and dyspnea.” https://t.co/UGmhtTo59w
@canadian_couple @yay_its_james https://t.co/TPkdwkCdjy
RT @littleann4ever: 9/ Let that sink in. Major organ damage. Oh yes, did they ever know. To add insult to injury, the PHSA also cited this…
LONG COVID https://t.co/ydEi5uInj8 9/7/2020 https://t.co/Yyi1TSFRwN 30/9/2020 https://t.co/0b6Lnmdv5L 31/7/2020 https://t.co/eimCle1l4q 1/11/2020 18/20 https://t.co/vvQCxK6tT1
RT @elisaperego78: In July 2020, Carfi et al. from Rome were reporting in @JAMANetwork that ~87% of 143 patients followed up around 60 days…
@DerAnsager @konnischeller @provoziert @st_hennermann @El_Heinzi Hier eine ganze Minute Internet verbracht, August 2020: Persistent Symptoms in Patients After Acute COVID-19 Sind zeitreisen auch eine Nebenwirkung der Impfung ? Boah !!! https://t.co/ZZY0KOHNPn
RT @elisaperego78: In July 2020, Carfi et al. from Rome were reporting in @JAMANetwork that ~87% of 143 patients followed up around 60 days…
RT @elisaperego78: In July 2020, Carfi et al. from Rome were reporting in @JAMANetwork that ~87% of 143 patients followed up around 60 days…
In July 2020, Carfi et al. from Rome were reporting in @JAMANetwork that ~87% of 143 patients followed up around 60 days after symptom onset were still symptomatic https://t.co/WnH1RQh6gr
@georgevanhouts Hier een artikel over long-covid toen het woord nog niet was uitgevonden, ik kan tientallen studies inclusief data aanhalen waaruit blijkt covid-19 heel veel schade kan veroorzaken, ook op de lange termijn https://t.co/5y8Xhoh7Rt
https://t.co/hflQ5QlmNS https://t.co/Svl5nEYRzj https://t.co/qmTer8bwQH https://t.co/tKkYtZp2oI https://t.co/jSI1DMVogf https://t.co/kIgPKjgMWe https://t.co/E5HnyXiYcE
RT @littleann4ever: 9/ Let that sink in. Major organ damage. Oh yes, did they ever know. To add insult to injury, the PHSA also cited this…
RT @littleann4ever: 9/ Let that sink in. Major organ damage. Oh yes, did they ever know. To add insult to injury, the PHSA also cited this…
RT @littleann4ever: 9/ Let that sink in. Major organ damage. Oh yes, did they ever know. To add insult to injury, the PHSA also cited this…
RT @littleann4ever: 9/ Let that sink in. Major organ damage. Oh yes, did they ever know. To add insult to injury, the PHSA also cited this…
RT @littleann4ever: 9/ Let that sink in. Major organ damage. Oh yes, did they ever know. To add insult to injury, the PHSA also cited this…
@CDCEnvironment Look at #SARSCoV2 Its intrinsic virulent https://t.co/fhDpnUjBDP
RT @tzYbHjEbLvnRi9w: ①2020年夏 “持続的な症状”として報告 (多分)最初の論文ですね 2020年7月9日付で公開されています フランスで120人を対象にして、発症約3か月後でも30%に記憶障害や睡眠障害などがみられたという内容でした https://…
①2020年夏 “持続的な症状”として報告 (多分)最初の論文ですね 2020年7月9日付で公開されています フランスで120人を対象にして、発症約3か月後でも30%に記憶障害や睡眠障害などがみられたという内容でした https://t.co/2cMiOoRfTz
RT @elisaperego78: By July 2020 persistent symptoms (Carfi et al.) and sequelae such as cardiac complications even in mild/asymptomatic pat…
RT @elisaperego78: "87.4% reported persistence of at least 1 symptom, particularly fatigue and dyspnea" for at least 2 months post hospital…
RT @elisaperego78: "87.4% reported persistence of at least 1 symptom, particularly fatigue and dyspnea" for at least 2 months post hospital…
RT @elisaperego78: "87.4% reported persistence of at least 1 symptom, particularly fatigue and dyspnea" for at least 2 months post hospital…
RT @elisaperego78: "87.4% reported persistence of at least 1 symptom, particularly fatigue and dyspnea" for at least 2 months post hospital…
RT @elisaperego78: "87.4% reported persistence of at least 1 symptom, particularly fatigue and dyspnea" for at least 2 months post hospital…
RT @elisaperego78: "87.4% reported persistence of at least 1 symptom, particularly fatigue and dyspnea" for at least 2 months post hospital…
RT @elisaperego78: "87.4% reported persistence of at least 1 symptom, particularly fatigue and dyspnea" for at least 2 months post hospital…
RT @elisaperego78: "87.4% reported persistence of at least 1 symptom, particularly fatigue and dyspnea" for at least 2 months post hospital…
"87.4% reported persistence of at least 1 symptom, particularly fatigue and dyspnea" for at least 2 months post hospitalization Carfi et al. @JAMA_current Published on 9 July 2020 https://t.co/WnH1RQh6gr
RT @ymori117: ロングCOVID(コロナ後遺症)の報道は欧米のほうが日本より先行していて、初期の論文は2020年7月には出ている。一般メディアでは2021年秋ごろからCNN、ニューヨークタイムズ、ガーディアンといった世界的なメディアで何度も報道さている。https:…
RT @ymori117: ロングCOVID(コロナ後遺症)の報道は欧米のほうが日本より先行していて、初期の論文は2020年7月には出ている。一般メディアでは2021年秋ごろからCNN、ニューヨークタイムズ、ガーディアンといった世界的なメディアで何度も報道さている。https:…
RT @ymori117: ロングCOVID(コロナ後遺症)の報道は欧米のほうが日本より先行していて、初期の論文は2020年7月には出ている。一般メディアでは2021年秋ごろからCNN、ニューヨークタイムズ、ガーディアンといった世界的なメディアで何度も報道さている。https:…
RT @ymori117: ロングCOVID(コロナ後遺症)の報道は欧米のほうが日本より先行していて、初期の論文は2020年7月には出ている。一般メディアでは2021年秋ごろからCNN、ニューヨークタイムズ、ガーディアンといった世界的なメディアで何度も報道さている。https:…
RT @ymori117: ロングCOVID(コロナ後遺症)の報道は欧米のほうが日本より先行していて、初期の論文は2020年7月には出ている。一般メディアでは2021年秋ごろからCNN、ニューヨークタイムズ、ガーディアンといった世界的なメディアで何度も報道さている。https:…
RT @ymori117: ロングCOVID(コロナ後遺症)の報道は欧米のほうが日本より先行していて、初期の論文は2020年7月には出ている。一般メディアでは2021年秋ごろからCNN、ニューヨークタイムズ、ガーディアンといった世界的なメディアで何度も報道さている。https:…
RT @ymori117: ロングCOVID(コロナ後遺症)の報道は欧米のほうが日本より先行していて、初期の論文は2020年7月には出ている。一般メディアでは2021年秋ごろからCNN、ニューヨークタイムズ、ガーディアンといった世界的なメディアで何度も報道さている。https:…
RT @ymori117: ロングCOVID(コロナ後遺症)の報道は欧米のほうが日本より先行していて、初期の論文は2020年7月には出ている。一般メディアでは2021年秋ごろからCNN、ニューヨークタイムズ、ガーディアンといった世界的なメディアで何度も報道さている。https:…
RT @ymori117: ロングCOVID(コロナ後遺症)の報道は欧米のほうが日本より先行していて、初期の論文は2020年7月には出ている。一般メディアでは2021年秋ごろからCNN、ニューヨークタイムズ、ガーディアンといった世界的なメディアで何度も報道さている。https:…
RT @ymori117: ロングCOVID(コロナ後遺症)の報道は欧米のほうが日本より先行していて、初期の論文は2020年7月には出ている。一般メディアでは2021年秋ごろからCNN、ニューヨークタイムズ、ガーディアンといった世界的なメディアで何度も報道さている。https:…
RT @ymori117: ロングCOVID(コロナ後遺症)の報道は欧米のほうが日本より先行していて、初期の論文は2020年7月には出ている。一般メディアでは2021年秋ごろからCNN、ニューヨークタイムズ、ガーディアンといった世界的なメディアで何度も報道さている。https:…
RT @ymori117: ロングCOVID(コロナ後遺症)の報道は欧米のほうが日本より先行していて、初期の論文は2020年7月には出ている。一般メディアでは2021年秋ごろからCNN、ニューヨークタイムズ、ガーディアンといった世界的なメディアで何度も報道さている。https:…
RT @ymori117: ロングCOVID(コロナ後遺症)の報道は欧米のほうが日本より先行していて、初期の論文は2020年7月には出ている。一般メディアでは2021年秋ごろからCNN、ニューヨークタイムズ、ガーディアンといった世界的なメディアで何度も報道さている。https:…
RT @ymori117: ロングCOVID(コロナ後遺症)の報道は欧米のほうが日本より先行していて、初期の論文は2020年7月には出ている。一般メディアでは2021年秋ごろからCNN、ニューヨークタイムズ、ガーディアンといった世界的なメディアで何度も報道さている。https:…
ロングCOVID(コロナ後遺症)の報道は欧米のほうが日本より先行していて、初期の論文は2020年7月には出ている。一般メディアでは2021年秋ごろからCNN、ニューヨークタイムズ、ガーディアンといった世界的なメディアで何度も報道さている。https://t.co/NfUzCijaSg https://t.co/wcn4mZ3X6u
RT @elisaperego78: By July 2020 persistent symptoms (Carfi et al.) and sequelae such as cardiac complications even in mild/asymptomatic pat…
RT @elisaperego78: By July 2020 persistent symptoms (Carfi et al.) and sequelae such as cardiac complications even in mild/asymptomatic pat…
RT @elisaperego78: By July 2020 persistent symptoms (Carfi et al.) and sequelae such as cardiac complications even in mild/asymptomatic pat…
RT @elisaperego78: By July 2020 persistent symptoms (Carfi et al.) and sequelae such as cardiac complications even in mild/asymptomatic pat…
RT @elisaperego78: By July 2020 persistent symptoms (Carfi et al.) and sequelae such as cardiac complications even in mild/asymptomatic pat…
RT @elisaperego78: By July 2020 persistent symptoms (Carfi et al.) and sequelae such as cardiac complications even in mild/asymptomatic pat…
RT @elisaperego78: By July 2020 persistent symptoms (Carfi et al.) and sequelae such as cardiac complications even in mild/asymptomatic pat…
RT @elisaperego78: By July 2020 persistent symptoms (Carfi et al.) and sequelae such as cardiac complications even in mild/asymptomatic pat…
RT @elisaperego78: By July 2020 persistent symptoms (Carfi et al.) and sequelae such as cardiac complications even in mild/asymptomatic pat…
RT @elisaperego78: By July 2020 persistent symptoms (Carfi et al.) and sequelae such as cardiac complications even in mild/asymptomatic pat…
RT @elisaperego78: By July 2020 persistent symptoms (Carfi et al.) and sequelae such as cardiac complications even in mild/asymptomatic pat…
By July 2020 persistent symptoms (Carfi et al.) and sequelae such as cardiac complications even in mild/asymptomatic patients (Puntmann et al.) after Covid were being reported in major medical journal, like JAMA https://t.co/RA22Pxu1gB https://t.co/WnH1RQh6gr
@normanpie https://t.co/jxRy726VyZ
RT @wolfeagle1989: @AndyMac84956921 @AudreyMagel @1goodtern When were vaccines available? December 2020? Patients assessed April 21 to May…
@AndyMac84956921 @AudreyMagel @1goodtern Oops, I repeated Wan et al, but here’s a study I missed: Patients assessed April 21 to May 29, 2020, published July 9, 2020: Carfì et al, “Persistent Symptoms in Patients After Acute COVID-19“, JAMA Network, https://t.co/nBvP25qdWX
@AndyMac84956921 @AudreyMagel @1goodtern When were vaccines available? December 2020? Patients assessed April 21 to May 29, 2020, published July 9, 2020: Carfì et al, “Persistent Symptoms in Patients After Acute COVID-19“, JAMA Network, https://t.co/nBvP25qdWX
@shaunsomers @jason1973bob @Scienceynerdt Long covid was identified several months before the vaccines were available. https://t.co/1FcnQkPLhq https://t.co/tu5fFKNTbW
@mamasels1963 @Gluonsrule @CTVNews https://t.co/1FcnQky9SQ August 2020
Referencias: • WHO consultada 18/12/21: https://t.co/mFjq293GJ4 • https://t.co/PdtPAYbyNh • Dilaura, G. (2021). Persistent Symptoms in Patients After Acute COVID-19. 324(6), 2020–2022. https://t.co/76I7sl0GVm
#Mentalízate con nosotros #mentalizarte #hablemosdesaludmental #saludmentalycovid #covid_19 Referencias: Dilaura, G. (2021). Persistent Symptoms in Patients After Acute COVID-19. 324(6), 2020–2022. https://t.co/76I7slihMU
RT @obscovid19br: Referências: 1) Carfi A, Bernabei R, Landi F & Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms…
Referências: 1) Carfi A, Bernabei R, Landi F & Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. J. Am. Med. Assoc 324, 603–605 (2020).
RT @elisaperego78: Again in summer 2020, Carfi et al published a research letter in @JAMA_current on "persistent symptoms in patients after…
RT @elisaperego78: Again in summer 2020, Carfi et al published a research letter in @JAMA_current on "persistent symptoms in patients after…
Again in summer 2020, Carfi et al published a research letter in @JAMA_current on "persistent symptoms in patients after acute covid 19" Based on a sample of 143 hospitalized patients, they showed only 12% of survivors were symptoms free ~60 days from onset | mean age 56 years
RT @rolandoug: Las primeras publicaciones
RT @rolandoug: Las primeras publicaciones
RT @rolandoug: Las primeras publicaciones
RT @rolandoug: Las primeras publicaciones
Las primeras publicaciones
Sempre a proposito dell’ inutilità dei vaccini #Covid_19 sostenuta dai #novax. Persistent Symptoms in Patients After Acute COVID-19 https://t.co/iHtttYj1VM via @JAMA_current part of @JAMANetwork
RT @Fizz_DI: ・mRNAワクチンの臨床試験 https://t.co/IYOklKwRau ・mRNAワクチンの副反応 https://t.co/fl3C7wIfH7 ・COVID-19患者の、退院後60日の再入院率と死亡率 https://t.co/BoweYq8…
RT @INPRFM: #hablemosdesaludmental #saludmentalycovid #covid_19 Referencias: Dilaura, G. (2021). Persistent Symptoms in Patients After Ac…
RT @INPRFM: #hablemosdesaludmental #saludmentalycovid #covid_19 Referencias: Dilaura, G. (2021). Persistent Symptoms in Patients After Ac…
Referencias: Dilaura, G. (2021). Persistent Symptoms in Patients After Acute COVID-19. 324(6), 2020–2022. https://t.co/KMGGNeXKhg Troyer, E. A., Kohn, J. N., & Hong, S. (2020). Brain Behavior and Immunity, 87(April), 34–39. https://t.co/DX1RZCNKHt
#hablemosdesaludmental #saludmentalycovid #covid_19 Referencias: Dilaura, G. (2021). Persistent Symptoms in Patients After Acute COVID-19. 324(6), 2020–2022. https://t.co/76I7sl0GVm
#hablemosdesaludmental #saludmentalycovid #covid_19 Referencias: • WHO consultada 18/12/21: https://t.co/mFjq293GJ4 https://t.co/PdtPAYbyNh • Dilaura, G. (2021). Persistent Symptoms in Patients After Acute COVID-19. 324(6), 2020–2022. https://t.co/76I7sl0GVm
@HKhash1 @wworeww1 @STW3X8YHYcL4wH5 専門家個人の意見ってエビデンスレベルとしてはとても低いです
Persistent Symptoms in Patients After Acute COVID-19 https://t.co/WxtcUevpBi via @JAMA_current part of @JAMANetwork
3~6割の人に疲労感や呼吸困難、関節痛等の後遺症 https://t.co/cXrSEyKKm7 44.1%にQOL低下、10%味覚・嗅覚障害残る https://t.co/DB2QeBpMj5 一度退院しても、再入院/死亡するリスクが高くなる https://t.co/rk9YBC6veF 後遺症で4割が仕事復帰に支障 https://t.co/ORSuQpl2gs https://t.co/ttbGoUcVpf
@namalgeria • صداع • تسارع دقات القلب • فقدان حاسة الشم و الذوق • الاكتئاب و القلق • الدوار • الحمى [المرجع بتصرف: Carfi A, et al. Persistent symptoms in patients after acute COVID-19. JAMA. 2020; doi:10.1001/jama.2020.12603. Teneforde MW, et al. ]
RT @DJELIDAY: • اضطراب في التركيز • صداع • تسارع دقات القلب • فقدان حاسة الشم و الذوق • الاكتئاب و القلق • الدوار • الحمى [المرجع بتصرف: C…
RT @DJELIDAY: • اضطراب في التركيز • صداع • تسارع دقات القلب • فقدان حاسة الشم و الذوق • الاكتئاب و القلق • الدوار • الحمى [المرجع بتصرف: C…
RT @DJELIDAY: • اضطراب في التركيز • صداع • تسارع دقات القلب • فقدان حاسة الشم و الذوق • الاكتئاب و القلق • الدوار • الحمى [المرجع بتصرف: C…
• اضطراب في التركيز • صداع • تسارع دقات القلب • فقدان حاسة الشم و الذوق • الاكتئاب و القلق • الدوار • الحمى [المرجع بتصرف: Carfi A, et al. Persistent symptoms in patients after acute COVID-19. JAMA. 2020; doi:10.1001/jama.2020.12603. Teneforde MW, et al. ]
@CamLuvsTacos @bearbeer1111 @midwestsweetie @Fourth_Stooge @Heminator @schwingcat Published studies indicate that 50% to 80% of patients continue to have bothersome symptoms three months after the onset of COVID. Here's two studies that support: https://t.co/2Hd0XsYGCl https://t.co/IhwtIQzaT5
@stopbeingmorons @NotAVaxxLabRat @8NewsNow I don’t think it matters, but here you go. https://t.co/rw7LKJNdsD https://t.co/TI4RGymVKx
@yuyake03 @pinktochumi @Tensuke922 以下エビデンスです
@MortWeaz @Wesley_Shinto @markminervini > Survival rates do not capture the true burden of disease. Long COVID and severe disease exists too +https://t.co/rb1PTlNQYD +https://t.co/YeaaRMmzSG +https://t.co/M3vQA8FJPJ .
RT @matiere: (2020/07/09) Persistent Symptoms in Patients After Acute COVID-19 | Critical Care Medicine | JAMA | JAMA Network https://t.co/…
@iikLJRS5oG6plWn @panna_wendy あたなはコロナ絶対ないの残念脳なので、絶対に読まないと思いますけど、一応根拠となる論文を示しておきますね笑 https://t.co/mxCo0Fy2hW https://t.co/eQhcATthNp https://t.co/vXlVzld4sf https://t.co/mxCo0Fy2hW
@KrzysztofAtor https://t.co/Enib2jowWG
@mc93823939 @ThereseEmber Nope - the Virus is serious and caused a lot of excess mortality in 2020. This too: +https://t.co/rb1PTlNQYD +https://t.co/8jzICZ72pX +https://t.co/YeaaRMmzSG +https://t.co/yulGjmlog8 +https://t.co/wsOWI9FqK4 +https://t.co/M3vQA8FJPJ +https://t.co/swsn0rEY0H https://t.co/zf0msoJsVN
Przechodzą COVID-19 bezobjawowo. Potem: niewydolność serca, przeszczep p... https://t.co/GKCj1oFGqz via @YouTube
@eco_nie Tu warto posłuchać co się dzieje jeśli się nie zaszczepimy https://t.co/bxobYk2yrw
@lukaszb99 @WilkoszKarol Mam już. Posłuchaj tego https://t.co/bxobYk2yrw
@DixieGenX You assume they FULLY recover, but your survival rates fail to capture this +https://t.co/rb1PTlNQYD +https://t.co/8jzICZ72pX +https://t.co/YeaaRMmzSG +https://t.co/yulGjmlog8 +https://t.co/wsOWI9FqK4 +https://t.co/M3vQA8FJPJ +https://t.co/UqURJMktbg .
RT @LechMucha: Dla tych wszystkich, co to uwierzyli w brednie pana Brauna et consortes. https://t.co/WCTzcm6gPm
RT @LechMucha: Dla tych wszystkich, co to uwierzyli w brednie pana Brauna et consortes. https://t.co/WCTzcm6gPm
Tylko dla osób młodych, wytrenowanych, wyćwiczonych, umięśnionych po łagodnym przebyciu #COVID19.. https://t.co/1ktwVLZWo5
RT @LechMucha: Dla tych wszystkich, co to uwierzyli w brednie pana Brauna et consortes. https://t.co/WCTzcm6gPm
RT @LechMucha: Dla tych wszystkich, co to uwierzyli w brednie pana Brauna et consortes. https://t.co/WCTzcm6gPm
RT @LechMucha: Dla tych wszystkich, co to uwierzyli w brednie pana Brauna et consortes. https://t.co/WCTzcm6gPm
RT @LechMucha: Dla tych wszystkich, co to uwierzyli w brednie pana Brauna et consortes. https://t.co/WCTzcm6gPm
RT @LechMucha: Dla tych wszystkich, co to uwierzyli w brednie pana Brauna et consortes. https://t.co/WCTzcm6gPm
RT @LechMucha: Dla tych wszystkich, co to uwierzyli w brednie pana Brauna et consortes. https://t.co/WCTzcm6gPm
Dla tych wszystkich, co to uwierzyli w brednie pana Brauna et consortes. https://t.co/WCTzcm6gPm
@bazemore @slane_mason @BreitbartNews Yup! Not to mention those with PASC +https://t.co/8jzICZ72pX +https://t.co/YeaaRMmzSG +https://t.co/yulGjmlog8 +https://t.co/wsOWI9FqK4 +https://t.co/M3vQA8FJPJ +https://t.co/swsn0rEY0H ++https://t.co/rb1PTlNQYD .
@Alinglese @CharlieEmmaUK If there is no Virus, then what is causing this? +https://t.co/rb1PTlNQYD +https://t.co/8jzICZ72pX +https://t.co/YeaaRMmzSG +https://t.co/yulGjmlog8 +https://t.co/wsOWI9FqK4 +https://t.co/M3vQA8FJPJ +https://t.co/swsn0rEY0H
@SimonSaid27 @DFuddrucker @JenniferMarguli These sound rather unique to me +https://t.co/rb1PTm5rQb +https://t.co/8jzICYPr1n +https://t.co/YeaaRM4Yu6 +https://t.co/yulGjmCZ7G +https://t.co/wsOWI9nPlu +https://t.co/M3vQA8o8r9 +https://t.co/swsn0rnmC7
@REALITYofJNJ You should be worrying about the LTEs of COVID-19 +https://t.co/rb1PTlNQYD +https://t.co/8jzICZ72pX +https://t.co/YeaaRMmzSG +https://t.co/yulGjmlog8 +https://t.co/wsOWI9FqK4 +https://t.co/M3vQA8FJPJ +https://t.co/swsn0rEY0H
@exhaustednurse_ No, the symptoms are much different +https://t.co/rb1PTlNQYD +https://t.co/8jzICZ72pX +https://t.co/YeaaRMmzSG +https://t.co/yulGjmlog8 +https://t.co/wsOWI9FqK4 +https://t.co/M3vQA8FJPJ +https://t.co/swsn0rEY0H
RT @dronita_de: Persistent Symptoms in Patients After Acute COVID-19 https://t.co/FxGUdgMQyq #DHPSP
RT @dronita_de: Persistent Symptoms in Patients After Acute COVID-19 https://t.co/FxGUdgMQyq #DHPSP
Persistent Symptoms in Patients After Acute COVID-19 https://t.co/FxGUdgMQyq #DHPSP
@Toluii The Flu also doesn't cause this +https://t.co/rb1PTlNQYD +https://t.co/8jzICZ72pX +https://t.co/YeaaRMmzSG +https://t.co/yulGjmlog8 +https://t.co/wsOWI9FqK4 +https://t.co/M3vQA8FJPJ +https://t.co/swsn0rEY0H Also: +https://t.co/XMLMrmoWWO https://t.co/YZXphIYnrA
@curepeachlove @Ny8G7 @cozytahara @nico_nico_news ちなみに若い人でも約1.0%ですが、高齢者では約10.0%と、致死率が高いです 加えて、3~6割の人に疲労感や呼吸困難、関節痛などの後遺症が現れます https://t.co/xfW1ijuoyV さらにQOLの低下が44.1%の感染者で起こり、味覚・嗅覚障害も10%ほど残ります https://t.co/eQhcATthNp
@BobPfalzgraf @mcfunny +https://t.co/rb1PTlNQYD +https://t.co/8jzICZ72pX +https://t.co/YeaaRMmzSG +https://t.co/yulGjmlog8 +https://t.co/wsOWI9FqK4 +https://t.co/M3vQA8FJPJ +https://t.co/swsn0rEY0H https://t.co/xrdNC7pyBj
@chrschwaegerl @reinboth @rki_de 10.1001/jama.2020.12603 > Das sind hospitalisierte Patienten -> also die kleine "Spitze" der Infizierten.
@SuperBenJman The >1,000,000 people in the UK with long COVID seeing this tweet like
Persistent Symptoms in Patients After Acute COVID-19 https://t.co/zd3xoreyLZ
@spencermorgan93 Hi Spencer! You're a piece of shit. You're not a Doctor - you don't determine who is suffering and who is not. If you can, tell me about these people +https://t.co/YeaaRMmzSG +https://t.co/M3vQA8FJPJ +https://t.co/swsn0rEY0H +https://t.co/yulGjmlog8
@revolutionvote https://t.co/wXXDQqNmO0 And https://t.co/ZVbnWymchK Read.
RT @mac_chango: Por fin aparecen ya publicaciones en revistas de impacto que apoyan a los que todavía nos sentimos mal postCOVID. A los 60…
RT @mac_chango: Por fin aparecen ya publicaciones en revistas de impacto que apoyan a los que todavía nos sentimos mal postCOVID. A los 60…
@NotpcT Another thing. Long term effects of COVID-19. Have you seen what it is doing to people? +https://t.co/rb1PTlNQYD +https://t.co/8jzICZ72pX +https://t.co/YeaaRMmzSG +https://t.co/yulGjmlog8 +https://t.co/wsOWI9FqK4 +https://t.co/M3vQA8FJPJ +https://t.co/M3vQA8FJPJ
@AZFakeLawyer PASC Sources: +https://t.co/rb1PTm5rQb +https://t.co/8jzICYPr1n +https://t.co/YeaaRM4Yu6 +https://t.co/yulGjmCZ7G +https://t.co/wsOWI9nPlu +https://t.co/M3vQA8o8r9 +https://t.co/M3vQA8o8r9 +https://t.co/swsn0rnmC7
@adamfarren2 500,000 dead Americans would disagree with you - so would these people: +https://t.co/yulGjmlog8 +https://t.co/wsOWI9FqK4 +https://t.co/swsn0rEY0H +https://t.co/M3vQA8FJPJ
@jens_140081 @R_Droite HIer eine Auswahl für die 10% doi:10.1001/jamacardio.2020.3557 DOI: 10.1056/NEJMc2018688 DOI: 10.1001/jama.2020.12603 Muß man dann halt noch zusammenrechnen
@rivensigns Here are my Sources: +https://t.co/yMOUru85wB +https://t.co/yulGjmlog8 +https://t.co/wsOWI9FqK4 +https://t.co/M3vQA8FJPJ +https://t.co/swsn0rEY0H +https://t.co/lWHhyyiOsA +https://t.co/DAWOV9HFdA +https://t.co/uD5Jz418nn https://t.co/vlrF3UVYei
Persistent Symptoms in Patients After Acute COVID-19 #LongCovid https://t.co/RBpQsPGsxd
@ACSial Also, if you wanna talk about "poison" +https://t.co/Cjxuq6sReS +https://t.co/hR38f2hH0O +https://t.co/yulGjmlog8 +https://t.co/M3vQA8FJPJ +https://t.co/swsn0rEY0H https://t.co/wsOWI9FqK4
Persistent Symptoms in Patients After Acute COVID-19 | Critical Care Medicine | JAMA | JAMA Network https://t.co/RrrBw0RP9b
Persistent Symptoms in Patients After Acute COVID-19 https://t.co/wbEhJpQsKi #LongCOVID 272/?
@ISlovan @Ra2myl @apresj20 ces deux-ci apparemment, sauf si je les ai ratées dans le ggl doc: https://t.co/3zsbTExu0R https://t.co/b4D2aoJt8l
@Ra2myl Etudes cliniques dans le BMJ, le MMWR et le JAMA https://t.co/0TeSPBwrRU https://t.co/CcTarCUEQg https://t.co/3zsbTExu0R
Persistent Symptoms in Patients After Acute COVID-19 https://t.co/RAifaVTo7x via @JAMA_current part of @JAMANetwork
RT @Fizz_DI: ・mRNAワクチンの臨床試験 https://t.co/IYOklKwRau ・mRNAワクチンの副反応 https://t.co/fl3C7wIfH7 ・COVID-19患者の、退院後60日の再入院率と死亡率 https://t.co/BoweYq8…
RT @Fizz_DI: ・mRNAワクチンの臨床試験 https://t.co/IYOklKwRau ・mRNAワクチンの副反応 https://t.co/fl3C7wIfH7 ・COVID-19患者の、退院後60日の再入院率と死亡率 https://t.co/BoweYq8…
RT @Fizz_DI: ・mRNAワクチンの臨床試験 https://t.co/IYOklKwRau ・mRNAワクチンの副反応 https://t.co/fl3C7wIfH7 ・COVID-19患者の、退院後60日の再入院率と死亡率 https://t.co/BoweYq8…
@apuakoronaan @Timotmie @KuronenJarmo @logan2_jj @pirijanne @MikaelNiku @riikka_kevo @TeeHool1 @1000histoires @anttipirttimaki @merja_rantala @MattiMuukkonen @unique_anonym @hi2_lo @MarkkuTanni @Tqwerty123a @AdamJKucharski @WHO @ECDC_EU @STM_Uutiset @THLorg @BorisJohnson @nytimes @MarkkuPeltonen Ensimmäinen on tämä: https://t.co/d7Fi7gaFxQ Tutkittu joukko on Italiassa SAIRAALAHOIDOSSA olleita.
RT @Fizz_DI: ・mRNAワクチンの臨床試験 https://t.co/IYOklKwRau ・mRNAワクチンの副反応 https://t.co/fl3C7wIfH7 ・COVID-19患者の、退院後60日の再入院率と死亡率 https://t.co/BoweYq8…
RT @Fizz_DI: ・mRNAワクチンの臨床試験 https://t.co/IYOklKwRau ・mRNAワクチンの副反応 https://t.co/fl3C7wIfH7 ・COVID-19患者の、退院後60日の再入院率と死亡率 https://t.co/BoweYq8…
RT @Fizz_DI: ・mRNAワクチンの臨床試験 https://t.co/IYOklKwRau ・mRNAワクチンの副反応 https://t.co/fl3C7wIfH7 ・COVID-19患者の、退院後60日の再入院率と死亡率 https://t.co/BoweYq8…
RT @Fizz_DI: ・mRNAワクチンの臨床試験 https://t.co/IYOklKwRau ・mRNAワクチンの副反応 https://t.co/fl3C7wIfH7 ・COVID-19患者の、退院後60日の再入院率と死亡率 https://t.co/BoweYq8…
RT @Fizz_DI: ・mRNAワクチンの臨床試験 https://t.co/IYOklKwRau ・mRNAワクチンの副反応 https://t.co/fl3C7wIfH7 ・COVID-19患者の、退院後60日の再入院率と死亡率 https://t.co/BoweYq8…
RT @Fizz_DI: ・mRNAワクチンの臨床試験 https://t.co/IYOklKwRau ・mRNAワクチンの副反応 https://t.co/fl3C7wIfH7 ・COVID-19患者の、退院後60日の再入院率と死亡率 https://t.co/BoweYq8…
RT @Fizz_DI: ・mRNAワクチンの臨床試験 https://t.co/IYOklKwRau ・mRNAワクチンの副反応 https://t.co/fl3C7wIfH7 ・COVID-19患者の、退院後60日の再入院率と死亡率 https://t.co/BoweYq8…
RT @Fizz_DI: ・mRNAワクチンの臨床試験 https://t.co/IYOklKwRau ・mRNAワクチンの副反応 https://t.co/fl3C7wIfH7 ・COVID-19患者の、退院後60日の再入院率と死亡率 https://t.co/BoweYq8…
RT @Fizz_DI: ・mRNAワクチンの臨床試験 https://t.co/IYOklKwRau ・mRNAワクチンの副反応 https://t.co/fl3C7wIfH7 ・COVID-19患者の、退院後60日の再入院率と死亡率 https://t.co/BoweYq8…
RT @Fizz_DI: ・mRNAワクチンの臨床試験 https://t.co/IYOklKwRau ・mRNAワクチンの副反応 https://t.co/fl3C7wIfH7 ・COVID-19患者の、退院後60日の再入院率と死亡率 https://t.co/BoweYq8…
RT @Fizz_DI: ・mRNAワクチンの臨床試験 https://t.co/IYOklKwRau ・mRNAワクチンの副反応 https://t.co/fl3C7wIfH7 ・COVID-19患者の、退院後60日の再入院率と死亡率 https://t.co/BoweYq8…
RT @Fizz_DI: ・mRNAワクチンの臨床試験 https://t.co/IYOklKwRau ・mRNAワクチンの副反応 https://t.co/fl3C7wIfH7 ・COVID-19患者の、退院後60日の再入院率と死亡率 https://t.co/BoweYq8…
・mRNAワクチンの臨床試験 https://t.co/IYOklKwRau ・mRNAワクチンの副反応 https://t.co/fl3C7wIfH7 ・COVID-19患者の、退院後60日の再入院率と死亡率 https://t.co/BoweYq85Rz ・COVID-19と季節性インフルエンザの比較 https://t.co/fiLGWpPPky ・COVID-19患者の後遺症調査 https://t.co/37dEmeaX9o
Persistent Symptoms in Patients After Acute COVID-19 https://t.co/w3IiBu4gMI @JAMA_current part of @JAMANetworkより
Persistent Symptoms in Patients After Acute COVID-19 https://t.co/oJpQA3a4pi @JAMA_current part of @JAMANetworkより
@ketoman25 @Karl_Lauterbach Vielleicht sollten Sie zu Longcovid einfach mal die aktuelle Studienlage verfolgen, statt sich hier mit Ihrem Unfug bloßzustellen. https://t.co/HZiTzJxdca https://t.co/dL17FMXkNF https://t.co/ZaAvwWkEqb
@rosenfeld_seth @vanbadham Persistent Symptoms in Patients After Acute COVID-19 (Jun 2020) https://t.co/ni41jOQmt9 & Management of post-acute covid-19 in primary care (Aug 2020) https://t.co/i37evrHMHa & Returning to physical activity after covid-19 (Jan 2021) https://t.co/026L6KljLj
Persistent Symptoms in Patients After Acute COVID-19 https://t.co/xPrp08gYsm via @JAMA_current part of @JAMANetwork
Persistent Symptoms in Patients After Acute COVID-19 https://t.co/rmQnHbP9Zu via @JAMA_current part of @JAMANetwork #covid19
Dr. Gude: Today, we will be discussing "Persistent Symptoms in Patients After Acute COVID-19" - they looked at patients after discharge #telemedicine #GGR #COVID19 https://t.co/F2Y5egsty3
Research Letter July 9, 2020 Persistent Symptoms in Patients After Acute COVID-19 https://t.co/vgEfbIIcGZ @JAMA_current part of @JAMANetworkより
Persistent Symptoms in Patients After Acute COVID-19 https://t.co/xS8STvkgX5
Persistent Symptoms in Patients After Acute COVID-19 https://t.co/i7ZGuPS9DV
RT @mcnang: Persistent Symptoms in Patients After Acute COVID-19 https://t.co/j7UAdVglI3 イタリアの研究。COVID-19感染者143人のうち、87.4%で後遺症が残った。
Persistent Symptoms in Patients After Acute COVID-19 https://t.co/j7UAdVglI3 イタリアの研究。COVID-19感染者143人のうち、87.4%で後遺症が残った。
@IoanAnthony @JayHarwood Read all of it + Carfì, A., Bernabei, R. and Landi, F. (2020) Persistent symptoms in patients after acute COVID-19. Dasgupta, A., Kalha, A. and Kalra, S. (2020) Long term complications and rehabilitation of COVID-19 patients. The Journal of the Pakistan Medical Association.
RT @ygjumi: Persistent Symptoms in Patients After Acute COVID-19 https://t.co/PUpZAv4PFh
@NathalieChris18 @srfnews Nicht so unhäufig (https://t.co/TDA1O6jubY) https://t.co/f1whxIobtU
53% aller #Corona Patienten leiden noch lange an Erschöpfung, gemäss einer italienischen Studie: Persistent Symptoms in Patients After Acute COVID-19 https://t.co/hmQOWcKq41 via @JAMA_current part of @JAMANetwork
Persistent Symptoms in Patients After Acute COVID-19 https://t.co/iG4VmvkyRr
RT @ygjumi: Persistent Symptoms in Patients After Acute COVID-19 https://t.co/PUpZAv4PFh
Persistent Symptoms in Patients After Acute COVID-19 https://t.co/PUpZAv4PFh
REFERENCIAS 1. Encuesta británica de la fatiga: https://t.co/PG4JDCgprY 2. Fatiga conductual: https://t.co/UUSaaF5CR7 3. Síntomas de pacientes post-covid: https://t.co/VQ6vE7leI9 4. Definición y Medición de la fatiga: https://t.co/lTcJIcFJFO 5. Confusión: https://t.co/OcBOOqbriB
11 de agosto 2020 Síntomas persistentes en pacientes después de un COVID-19 agudo https://t.co/2FjwmjrQTh
Long covidは正式な定義はないと思いますが、 『発症後60日経っても、一つ以上の症状を有する』 JAMA2020;9. doi:10.1001/jama.2020.12603. pmid:32644129 でいいんでしょうか??
RT @jnavarrosimon: Persistent Symptoms in Patients After Acute COVID-19 https://t.co/WVctsYpVYB
Persistent Symptoms in Patients After Acute COVID-19 https://t.co/WVctsYpVYB
Persistent Symptoms in Patients After Acute COVID-19 https://t.co/veUcz3ks1R a través de @JAMA_current part of @JAMANetwork
Persistent Symptoms in Patients After Acute COVID-19 https://t.co/GwAf0WOlHI @JAMA_current part of @JAMANetworkより
https://t.co/PrtGvbypAs #NuevaFotoDePerfil https://t.co/iEcavEm5lP
RT @MrDoctorOficial: #COVID19: ACTUALIZACIÓN | PREGUNTAS Y RESPUESTAS | VACUNA #PFIZER, REINFECCIONES, INMUNIDAD, SECUELAS HOY • 20:00 hrs…
Actualización del Covid-19 https://t.co/xOnjA6ixMR
RT @MrDoctorOficial: #COVID19: ACTUALIZACIÓN | PREGUNTAS Y RESPUESTAS | VACUNA #PFIZER, REINFECCIONES, INMUNIDAD, SECUELAS HOY • 20:00 hrs…
https://t.co/XNGHWmZdQ3
RT @MrDoctorOficial: #COVID19: ACTUALIZACIÓN | PREGUNTAS Y RESPUESTAS | VACUNA #PFIZER, REINFECCIONES, INMUNIDAD, SECUELAS HOY • 20:00 hrs…
RT @MrDoctorOficial: #COVID19: ACTUALIZACIÓN | PREGUNTAS Y RESPUESTAS | VACUNA #PFIZER, REINFECCIONES, INMUNIDAD, SECUELAS HOY • 20:00 hrs…
RT @MrDoctorOficial: Si quieren saber más actualizaciones de #COVID19, vayan a mi canal de YouTube: COVID19: ACTUALIZACIÓN | PREGUNTAS Y R…
RT @MrDoctorOficial: Si quieren saber más actualizaciones de #COVID19, vayan a mi canal de YouTube: COVID19: ACTUALIZACIÓN | PREGUNTAS Y R…
RT @MrDoctorOficial: #COVID19: ACTUALIZACIÓN | PREGUNTAS Y RESPUESTAS | VACUNA #PFIZER, REINFECCIONES, INMUNIDAD, SECUELAS HOY • 20:00 hrs…
#COVID19: ACTUALIZACIÓN | PREGUNTAS Y RESPUESTAS | VACUNA #PFIZER, REINFECCIONES, INMUNIDAD, SECUELAS HOY • 20:00 hrs • #YouTube https://t.co/PrtGvbypAs Realizamos una actualización de #COVID19 con fundamento científico y memes de #BobEsponja acerca de esta enfermedad. https://t.co/ZxnSwLv9D5
Si quieren saber más actualizaciones de #COVID19, vayan a mi canal de YouTube: COVID19: ACTUALIZACIÓN | PREGUNTAS Y RESPUESTAS | VACUNA #PFIZER, REINFECCIONES, INMUNIDAD, SECUELAS HOY • 20:00 hrs • #YouTube https://t.co/PrtGvbypAs https://t.co/6N1Ttk4sMI
JAMA 9 juillet Persistent Symptoms in Patients After Acute COVID-19 https://t.co/czlWqTF6L0 via @JAMA_current part of @JAMANetwork
#COVID19 akut hastalığı atlattıktan sonra, bir süre daha devam eden semptomlar: yorgunluk, nefes darlığı, eklem ve göğüs ağrısı, öksürük, tat ve koku alamama, sjögren sendromu, baş ağrısı, boğaz ağrısı.. https://t.co/B7OKdZHSr2
RT @dr_shibley: Persistent Symptoms in Patients After Acute COVID-19 https://t.co/IJAvXHYeVf via @JAMA_current part of @JAMANetwork
RT @dr_shibley: Persistent Symptoms in Patients After Acute COVID-19 https://t.co/IJAvXHYeVf via @JAMA_current part of @JAMANetwork
Persistent Symptoms in Patients After Acute COVID-19 https://t.co/IJAvXHYeVf via @JAMA_current part of @JAMANetwork
Persistent Symptoms in Patients After Acute COVID-19 https://t.co/kkjp5FxV7E @JAMA_current part of @JAMANetworkより
@p00b072nd @Ethanrix23 @T_Inglesby These were in that paper. https://t.co/pTx5LMvjik https://t.co/vF0QhoSm0p Again. Have a nice day.
RT @paolabel_cardio: Persistent Symptoms in Patients After Acute COVID-19 https://t.co/bnQ97XSEKT vía @JAMA_current part of @JAMANetwork
Persistent Symptoms in Patients After Acute COVID-19 | Critical Care Medicine | JAMA | JAMA Network https://t.co/AM7hGMlQmA
Persistent Symptoms in Patients After Acute COVID-19 https://t.co/bnQ97XSEKT vía @JAMA_current part of @JAMANetwork
RT @ygjumi: Persistent Symptoms in Patients After Acute COVID-19 https://t.co/PUpZAv4PFh
RT @ygjumi: Persistent Symptoms in Patients After Acute COVID-19 https://t.co/PUpZAv4PFh
RT @ygjumi: Persistent Symptoms in Patients After Acute COVID-19 https://t.co/PUpZAv4PFh
Persistent Symptoms in Patients After Acute COVID-19 https://t.co/PUpZAv4PFh
Persistent Symptoms in Patients After Acute COVID-19 | Critical Care Medicine | JAMA | JAMA Network https://t.co/Txp0zasm3i
Persistent Symptoms in Patients After Acute COVID-19 (July 2020) https://t.co/wbEhJpQsKi #LongCovid 52/?
Persistent Symptoms in Patients After Acute COVID-19 | Critical Care Medicine | JAMA | JAMA Network https://t.co/JQo5uuJOMA
Persistent Symptoms in Patients After Acute COVID-19 https://t.co/iN6E2GcLbD
@trishgreenhalgh Carfì A, Bernabei R, Landi F, for the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603–605. doi:10.1001/jama.2020.12603 https://t.co/CA0GGJugRV
RT @akarilmiah: https://t.co/97O4mOlbrV Grup peneliti di Italia mengumpulkan data dari pasien covid19 yang sudah dinyatakan bebas dari viru…
RT @akarilmiah: https://t.co/97O4mOlbrV Grup peneliti di Italia mengumpulkan data dari pasien covid19 yang sudah dinyatakan bebas dari viru…
RT @akarilmiah: https://t.co/97O4mOlbrV Grup peneliti di Italia mengumpulkan data dari pasien covid19 yang sudah dinyatakan bebas dari viru…
https://t.co/97O4mOlbrV Grup peneliti di Italia mengumpulkan data dari pasien covid19 yang sudah dinyatakan bebas dari virus itu. Ternyata, mereka tidak langsung sepenuhnya merasa 100%! Mereka mencatat apa saja yang masih dikeluhkan oleh orang-orang itu.
sumber: 1. Carfi A, Bernabei R, Landi F. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603-605. doi:10.1001/jama.2020.12603
RT @akarilmiah: gejala covid19 BANYAK https://t.co/v4pmWp4ylh di sini kita bahas sekilas gejala2 #covid19 dengan artikel sumber laporannya…
gejala covid19 BANYAK https://t.co/v4pmWp4ylh di sini kita bahas sekilas gejala2 #covid19 dengan artikel sumber laporannya. semoga sama-sama jadi bisa belajar lebih banyak dan menggali ilmu sampai ke akarnya!
RT @hibarra_neph: Persistent Symptoms in Patients After Acute #COVID19
#COVID19 Related Symptoms
Persistent Symptoms in Patients After Acute #COVID19
Fatigue, dyspnea persisting 60+ days after onset of symptoms among #COVIDー19 patients who were previously discharged from hospitals in Italy: https://t.co/evf6es4WvK
RT @dr_ezquerra:
@elycas2 @vane_r12 @DrPacoMoreno1 doi:10.1001/jama.2020.12603
Persistent symptoms and injury evolution #COVID19 doi:10.1001/jama.2020.12603 Landi, Bernabei, Carfi doi: https://t.co/rFFkl8PHtU Doglioni, Ravaglia https://t.co/ZJtAAbnqom
RT @dr_ezquerra:
Published Online: July 9, 2020. doi:10.1001/jama.2020.12603
RT @pagingdrayman: PERSISTENCE OF SYMPTOMS POST #COVID19. 87.4% reported persistence of at least 1 symptom a mean of 60.3 days after first…
PERSISTENCE OF SYMPTOMS POST #COVID19. 87.4% reported persistence of at least 1 symptom a mean of 60.3 days after first symptoms, particularly fatigue and dyspnea @atscommunity @EuroRespSoc @accpchest #MedTwitter https://t.co/fG9sUk7gdA https://t.co/OMYH8zfB21
RT @Neuro24de: Post COVID Syndrom, italienische Studie: Die Patienten wurden im Mittel 60(SD, 13,6) Tage nach Auftreten des ersten COVID-19…
RT @Neuro24de: Post COVID Syndrom, italienische Studie: Die Patienten wurden im Mittel 60(SD, 13,6) Tage nach Auftreten des ersten COVID-19…
RT @Neuro24de: Post COVID Syndrom, italienische Studie: Die Patienten wurden im Mittel 60(SD, 13,6) Tage nach Auftreten des ersten COVID-19…
RT @Neuro24de: Post COVID Syndrom, italienische Studie: Die Patienten wurden im Mittel 60(SD, 13,6) Tage nach Auftreten des ersten COVID-19…
Post COVID Syndrom, italienische Studie: Die Patienten wurden im Mittel 60(SD, 13,6) Tage nach Auftreten des ersten COVID-19-Symptoms untersucht; zum Zeitpunkt der Untersuchung waren nur 18 (12,6%) völlig frei von jeglichem COVID-19-bezogenen Symptom https://t.co/hUM5RxTYsR
RT @dr_ezquerra:
Cómo a varios de nuestros pacientes he comentado, una ves que ha cedido el cuadro agudo y se han recuperado, queda lo que podríamos llamar "Síndrome PostCovid". Si desean profundizar: https://t.co/3PcBq0Yert https://t.co/jIqe2Qpkys
Persistent Symptoms in Patients After Acute COVID-19 - PubMed https://t.co/Vi2uhXPnyN
RT @dr_ezquerra:
@kankan32980969 @nishy03 doi:10.1001/jama.2020.12603 によれば、種類によりだいたい1割〜5割に後遺症。それがどれだけ続くかはコロナ禍が始まったばかりなので不明 https://t.co/A9UNqGQUkI
RT @UchhalK: Post-recovery persistent symptoms after acute COVID-19: https://t.co/gTu6oRao5r https://t.co/JetP1rCziY
Post-recovery persistent symptoms after acute COVID-19: https://t.co/gTu6oRao5r https://t.co/JetP1rCziY
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @ClinicalRehab: DW. The top four symptoms nine weeks after onset of Covid-19 in an Italian study were: fatigue (56%), shortness of breat…
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
#SARS_CoV_2 A 60 días de la infección, sólo 18% no tenía ningún síntoma, 55% persistía con 3 síntomas. JAMA 2020 doi:10.1001/jama.2020.12603 https://t.co/TMFQZUsJeV
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @ClinicalRehab: DW. The top four symptoms nine weeks after onset of Covid-19 in an Italian study were: fatigue (56%), shortness of breat…
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @ClinicalRehab: DW. The top four symptoms nine weeks after onset of Covid-19 in an Italian study were: fatigue (56%), shortness of breat…
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
RT @dr_ezquerra:
DW. The top four symptoms nine weeks after onset of Covid-19 in an Italian study were: fatigue (56%), shortness of breath (42%), joint pain (27%), chest pain (22%). Headache (8%) and vertigo (4%) were the only 'neurological' symptoms. https://t.co/tRz2KH3pmY
@danspils @nevali we regards to the "just anecdote", at this stage yes, because it's so clinically new, but I would suggest https://t.co/uMPs5WpM6o https://t.co/JFMG8p13mU and the hashtag longcovid
Fast neun von zehn COVID-Patienten einer italienischen Beobachtungsstudie hatten nach der so genannten Genesung noch mindestens ein Symptom, insbesondere Fatigue und Dyspnoe. Mehr als 40 Prozent hatten eine verminderte Lebensqualität. https://t.co/XhuJ3NT9oO
Angelo Carfì et al. "Persistent Symptoms in Patients After Acute COVID-19". JAMA Network. 2020-07-09. https://t.co/2xpDDG7SSz, (accessed 2020-07-14). #COVID19 #SARSCoV2 #新型コロナウイルス感染症 #新型コロナウイルス https://t.co/KcHq1Tn1Q7
(2020/07/09) Persistent Symptoms in Patients After Acute COVID-19 | Critical Care Medicine | JAMA | JAMA Network https://t.co/dg25MB9uer
In @JAMA_current: Close to 90% of #COVID19 patients who were hospitalized still have at least one symptom (#fatigue, #dyspnea) 60 days after the first #coronavirus symptoms occurred. Article: https://t.co/O4Fr2sclL5 #medicine #research #Corona #SARSCoV2 #CoronaVirusUpdates
Post-COVID symptom persistence data from Italy. Evaluation was a mean of 2 months post-symptoms. https://jamanetwork.com/journals/jama/fullarticle/2768351
DP
U認